Hind Rectifiers Fair Value
Hind Rectifiers (HIRECT) average fair value is ₹222.9 across 5 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹1152.35 (-80.66%), fair value range ₹21.72–₹447.86. Examine HIRECT earnings report for recent quarterly revenue, profit and EPS trends.
Fair Value Analysis Export
HIRECT Fair Value vs Current Price — Valuation Summary
HIRECT average fair value, fair value range, price gap and valuation status across 5 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number. For live price and a broader fundamental view, visit Hind Rectifiers share price today.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
HIRECT Fair Value Analysis — Data Sources & Coverage
Hind Rectifiers financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. See HIRECT price book multiple to compare market price against book value per share.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
HIRECT vs Capital Goods Sector Peers — P/E, P/B & Market Cap
Hind Rectifiers P/E ratio, P/B ratio and market capitalisation vs Capital Goods sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Rajoo Engineers | RAJOOENG | 20.28 | 2.87 | ₹983 |
| KPT Industries | KPT | 13.25 | 2.19 | ₹164 |
| Equilateral Enterprises | EQUILATERA | 69.71 | 2.57 | ₹28 |
| Shantai Industries | SHANTAI | -91.75 | 9.69 | ₹77 |
| Avana Electrosystems | AVANA | - | 6.43 | ₹343 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.